ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium Hydroxide → 4-((3-chlorophenyl)amino)-3-hydroxy-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide formate

HRID 528568
印刷

反応式

HRID 528568 の反応式
[Cl:1][C:2]1[CH:3]=[C:4]([N:8]2[C:12]3[CH:13]=[CH:14][C:15]([S:17]([N:20](CC4C=CC(OC)=CC=4OC)[C:21]4[S:22][CH:23]=[N:24][N:25]=4)(=[O:19])=[O:18])=[CH:16][C:11]=3[O:10][C:9]2=[O:37])[CH:5]=[CH:6][CH:7]=1.[OH-].[Na+].[NH4+].[Cl-]>CO>[CH:9]([OH:37])=[O:10].[Cl:1][C:2]1[CH:3]=[C:4]([NH:8][C:12]2[CH:13]=[CH:14][C:15]([S:17]([NH:20][C:21]3[S:22][CH:23]=[N:24][N:25]=3)(=[O:18])=[O:19])=[CH:16][C:11]=2[OH:10])[CH:5]=[CH:6][CH:7]=1
参加物反応条件実験手順後処理出典と根拠反応ノート

参加物

5

反応物 3

HCID 14798Sodium HydroxideHCID 25517Ammonium ChlorideHCID 897613473-(3-chlorophenyl)-N-(2,4-dimethoxybenzyl)-2-oxo-N-(1,3,4-thiadiazol-2-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide

生成物 1

HCID 897619394-((3-chlorophenyl)amino)-3-hydroxy-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide formate

試薬・触媒・溶媒 1

HCID 887Methanol
溶媒

反応条件

温度
80 °C

実験手順

A sealable vial was charged with 3-(3-chlorophenyl)-N-(2,4-dimethoxybenzyl)-2-oxo-N-(1,3,4-thiadiazol-2-yl)-2,3-dihydrobenzo[d]oxazole-6-sulfonamide (38 mg, 0.068 mmol), and an aqueous solution of sodium hydroxide (2549 μL, 5.10 mmol) was added. The mixture was heated at 80° C. for 1 h, then poured into sat. aq. NH4Cl. The solution became heterogeneous, extracted with DCM, product did not go into organic layer, even after addition of brine. Aqueous layer was lyophilized to give product along with salts. The mixture was dissolved in MeOH and filtered to remove the majority of salts. The filtrate was concentrated onto Celite® (diatomaceous earth) and eluted through a pre-equilibrated C18 silica gel column (12 g) and eluted with a gradient of 95:5 1% formic acid in water: 1% formic acid in MeCN—10:90 1% formic acid in water: 1% formic acid in MeCN, followed by 100% IPA wash. The fractions containing desired product were concentrated to provide 4-((3-chlorophenyl)amino)-3-hydroxy-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide formate as a white amorphous solid. m/z (ESI) 383.1 (M+H)+.

後処理

  1. extractionextracted with DCM, product
  2. additioneven after addition of brine
  3. customto give product along with salts
  4. filtrationfiltered
  5. customto remove the majority of salts
  6. concentrationThe filtrate was concentrated onto Celite® (diatomaceous earth)
  7. washeluted through a pre-equilibrated C18 silica gel column (12 g)
  8. washeluted with a gradient of 95:5 1% formic acid in water
  9. washwash
  10. additionThe fractions containing desired product
  11. concentrationwere concentrated

出典と根拠

ORDレコード
ord-e5c14b6bc9834eed8e5e9c499401401b
出典データセット
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09346798B2

反応ノート

このページの内容参加物反応条件実験手順後処理出典と根拠反応ノート